02
By The Numbers*
50+
Our technology is backed by over 50 patents, protecting and advancing exclusive imaging and endoscopic capabilities.
Patents For Advancing Imaging and Endoscopic Capabilities
10x
Our single-use design is crafted with the goal of reducing cross-contamination risks by up to 10 times the current rate, supporting safer procedures for patients.
We Aim To Reduce Cross-Contamination Risks
30%
Our technology is developed to help streamline complex procedures, with the potential to reduce operating time and improve patient throughput.
Possible Reduction In Procedure Time With Improved Efficiency
1
Our endoscope is designed to contribute to cost efficiency, with the possibility of just one additional procedure offering measurable ROI.
Procedure Aims To Cover The Entire Unit Investment
99.99%
Our device aims to achieve illumination efficiency far beyond standard CMOS cameras, working to provide clear and precise imaging for diagnostics.
Illumination Efficiency Potential vs. Traditonal CMOS Solutions
40%
Our advanced imaging technology aspires to support higher success rates with the goal of improving patient outcomes.
Aiming For Higher Success Rates In Complex Cases
* Source: JACC: Cardiovascular Interventions. "Chronic Total Occlusion Percutaneous Coronary Interventions: Evidence, Techniques, and Outcomes." Accessed at https://www.jacc.org/doi/full/10.1016/j.jcin.2009.02.008.
PRESENTER:
Luis Savastano
DATE:
May 27, 2025
TIME:
4:00 PM (PST)
LOCATION:
Zoom
By popular request, we’re hosting a physician-focused deep dive into VerAvanti’s SFE (Scanning Fiber Endoscope) technology designed to advance how we image, understand and treat vascular and neurovascular diseases.
Why attend?
Join #LuisSavastano, VerAvanti’s Chief Medical Officer and a leader in vascular innovation, for an in-depth session and live Q&A covering:🔹 The clinical value and versatility of SFE imaging🔹 Real-world insights into carotid, coronary, and peripheral artery disease🔹 What’s next for research, prototypes, and clinical collaboration
About the Speaker
Dr. Savastano is a hybrid cerebrovascular neurosurgeon, inventor, and translational scientist. He leads Cerebrovascular and NeuroEndovascular Surgery at UCSF, where he also directs the TNTlab. His pioneering work in intravascular imaging is helping redefine minimally invasive diagnostics.
Who should attend:
This session is tailored for practicing MDs in vascular, neuro, cardiovascular, and endovascular specialties.
Be part of the innovation.
All attendees will be added to our early interest list for upcoming trials and prototype access.
Can’t make it?
Save this page for a future recording you can playback to view the event in full detail at your own convience.
#SFE #Neurovascular #EndovascularInnovation #MedTechWebinar #InterventionalRadiology #StrokeCare #CarotidDisease #ClinicalImaging #PhysicianEducation